| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.002 | 0.907 | Prostaglandin antagonist | 0.764 0.003 CID_154699956 0.788 0.003 CID_154699550 | ||
| 0.891 | 0.002 | 0.891 | Prostaglandin D2 antagonist | 0.641 0.002 CID_154699956 0.671 0.002 CID_154699550 | ||
| 0.864 | 0.004 | 0.864 | Platelet antagonist | 0.863 0.004 CID_154699956 0.859 0.004 CID_154699550 | ||
| 0.814 | 0.001 | 0.814 | Thromboxane antagonist | 0.803 0.001 CID_154699956 0.813 0.001 CID_154699550 | ||
| 0.811 | 0.001 | 0.811 | Thromboxane A2 antagonist | 0.799 0.001 CID_154699956 0.809 0.001 CID_154699550 | ||
| 0.72 | 0.007 | 0.797 | Antithrombotic | 0.771 0.005 CID_154699956 0.797 0.004 CID_154699550 | CID_154699550 | |
| 0.689 | 0.005 | 0.725 | Platelet aggregation inhibitor | 0.725 0.005 CID_154699956 0.684 0.005 CID_154699550 | CID_154699956 | |
| 0.498 | 0.002 | 0.498 | Thromboxane synthase inhibitor | 0.195 0.003 CID_154699956 0.211 0.003 CID_154699550 | ||
| 0.516 | 0.045 | 0.516 | Cyclophilin D inhibitor | 0.505 0.049 CID_154699956 0.408 0.086 CID_154699550 | ||
| 0.404 | 0.003 | 0.404 | Prostacyclin antagonist | 0.271 0.003 CID_154699956 0.287 0.003 CID_154699550 | ||
| 0.397 | 0.018 | 0.466 | Sodium/bile acid cotransporter inhibitor | 0.466 0.006 CID_154699956 0.466 0.006 CID_154699550 | CID_154699550 | |
| 0.431 | 0.055 | 0.464 | Antiobesity | 0.385 0.072 CID_154699956 0.464 0.046 CID_154699550 | CID_154699550 | |
| 0.372 | 0.015 | 0.377 | Diuretic | 0.377 0.014 CID_154699956 0.282 0.026 CID_154699550 | CID_154699956 | |
| 0.411 | 0.056 | 0.766 | Toll-Like receptor 7 agonist | 0.515 0.029 CID_154699956 0.766 0.005 CID_154699550 | CID_154699550 | |
| 0.406 | 0.058 | 0.759 | Toll-Like receptor agonist | 0.508 0.03 CID_154699956 0.759 0.006 CID_154699550 | CID_154699550 | |
| 0.331 | 0.022 | 0.331 | Non-steroidal antiinflammatory agent | 0.323 0.024 CID_154699956 0.285 0.031 CID_154699550 | ||
| 0.288 | 0.016 | 0.288 | Antipruritic | 0.24 0.028 CID_154699956 0.245 0.026 CID_154699550 | ||
| 0.318 | 0.049 | 0.536 | Cardiotonic | 0.39 0.031 CID_154699956 0.536 0.012 CID_154699550 | CID_154699550 | |
| 0.266 | 0.001 | 0.266 | Prostaglandin H2 antagonist | 0.092 0.002 CID_154699956 0.097 0.002 CID_154699550 | ||
| 0.285 | 0.045 | 0.287 | Gastrin inhibitor | 0.249 0.08 CID_154699956 0.287 0.043 CID_154699550 | CID_154699550 | |
| 0.282 | 0.055 | 0.282 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.105 CID_154699956 0.229 0.105 CID_154699550 | ||
| 0.222 | 0.007 | 0.222 | Pregnane X receptor agonist | 0.193 0.013 CID_154699956 0.219 0.007 CID_154699550 | ||
| 0.205 | 0.005 | 0.205 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.167 0.005 CID_154699956 0.118 0.009 CID_154699550 | ||
| 0.204 | 0.02 | 0.204 | GABA C receptor agonist | 0.126 0.046 CID_154699956 0.126 0.046 CID_154699550 | ||
| 0.191 | 0.009 | 0.191 | Electrolyte absorption antagonist | 0.143 0.022 CID_154699956 0.143 0.022 CID_154699550 | ||
| 0.251 | 0.076 | 0.263 | Hypoglycemic | 0.263 0.069 CID_154699956 0.262 0.07 CID_154699550 | CID_154699956 | |
| 0.229 | 0.068 | 0.26 | Peptidyltransferase inhibitor | 0.26 0.044 CID_154699956 0.26 0.044 CID_154699550 | CID_154699550 | |
| 0.221 | 0.061 | 0.312 | Platelet adhesion inhibitor | 0.312 0.03 CID_154699956 0.286 0.038 CID_154699550 | CID_154699956 | |
| 0.156 | 0.017 | 0.156 | Metalloproteinase-2 inhibitor | 0.105 0.036 CID_154699956 0.112 0.033 CID_154699550 | ||
| 0.241 | 0.105 | 0.241 | Insulysin inhibitor | |||
| 0.138 | 0.004 | 0.138 | Bombesin 3 receptor antagonist | 0.121 0.007 CID_154699956 0.07 0.024 CID_154699550 | ||
| 0.134 | 0.003 | 0.149 | Prostacyclin agonist | 0.14 0.003 CID_154699956 0.149 0.003 CID_154699550 | CID_154699550 | |
| 0.151 | 0.021 | 0.183 | CC chemokine 6 receptor antagonist | 0.183 0.005 CID_154699956 0.142 0.035 CID_154699550 | CID_154699956 | |
| 0.209 | 0.088 | 0.238 | Hypolipemic | 0.238 0.073 CID_154699956 0.213 0.085 CID_154699550 | CID_154699956 | |
| 0.22 | 0.103 | 0.22 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.247 | 0.13 | 0.339 | Apoptosis antagonist | 0.339 0.061 CID_154699956 0.324 0.07 CID_154699550 | CID_154699956 | |
| 0.183 | 0.068 | 0.337 | Lipocortins synthesis antagonist | 0.337 0.015 CID_154699956 0.337 0.015 CID_154699550 | CID_154699550 | |
| 0.242 | 0.128 | 0.26 | Interleukin 2 agonist | 0.26 0.108 CID_154699956 0.26 0.108 CID_154699550 | CID_154699550 | |
| 0.175 | 0.067 | 0.238 | Phospholipase C inhibitor | 0.238 0.028 CID_154699956 0.238 0.028 CID_154699550 | CID_154699550 | |
| 0.189 | 0.085 | 0.199 | Insulin sensitizer | 0.199 0.074 CID_154699956 0.17 0.108 CID_154699550 | CID_154699956 | |
| 0.128 | 0.027 | 0.169 | Carbonic anhydrase VI inhibitor | 0.169 0.017 CID_154699956 0.169 0.017 CID_154699550 | CID_154699550 | |
| 0.124 | 0.024 | 0.149 | Adrenaline agonist | 0.103 0.035 CID_154699956 0.149 0.015 CID_154699550 | CID_154699550 | |
| 0.105 | 0.009 | 0.105 | Glutamate (mGluR group III) agonist | 0.041 0.032 CID_154699956 0.066 0.016 CID_154699550 | ||
| 0.1 | 0.011 | 0.103 | Prostaglandin F2 alpha antagonist | 0.103 0.01 CID_154699956 0.103 0.01 CID_154699550 | CID_154699550 | |
| 0.092 | 0.007 | 0.092 | Secretase gamma inhibitor | 0.06 0.019 CID_154699956 0.046 0.028 CID_154699550 | ||
| 0.129 | 0.048 | 0.129 | Caspase 3 inhibitor | |||
| 0.101 | 0.022 | 0.101 | Neutrophil collagenase inhibitor | 0.057 0.055 CID_154699956 0.06 0.05 CID_154699550 | ||
| 0.092 | 0.014 | 0.107 | Glutamate (mGluR6) antagonist | 0.093 0.014 CID_154699956 0.107 0.008 CID_154699550 | CID_154699550 | |
| 0.118 | 0.046 | 0.138 | Bronchodilator | 0.138 0.036 CID_154699956 0.134 0.038 CID_154699550 | CID_154699956 | |
| 0.089 | 0.02 | 0.089 | Collagenase 3 inhibitor | 0.053 0.051 CID_154699550 | ||
| 0.131 | 0.063 | 0.131 | Nav1.3 sodium channel blocker | |||
| 0.146 | 0.078 | 0.146 | Insulin secretagoues | 0.129 0.098 CID_154699956 0.129 0.098 CID_154699550 | ||
| 0.096 | 0.028 | 0.096 | Epoxide hydrolase inhibitor | 0.064 0.062 CID_154699956 | ||
| 0.147 | 0.082 | 0.147 | Hexokinase inhibitor | 0.137 0.095 CID_154699956 0.137 0.095 CID_154699550 | ||
| 0.136 | 0.072 | 0.136 | Nav1.6 sodium channel blocker | |||
| 0.113 | 0.05 | 0.145 | Carbonic anhydrase III inhibitor | 0.145 0.03 CID_154699956 0.145 0.03 CID_154699550 | CID_154699550 | |
| 0.067 | 0.005 | 0.067 | Integrin alpha2 antagonist | 0.046 0.014 CID_154699956 0.037 0.025 CID_154699550 | ||
| 0.078 | 0.017 | 0.078 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.036 CID_154699956 0.055 0.036 CID_154699550 | ||
| 0.083 | 0.024 | 0.083 | Carbonic anhydrase stimulant | |||
| 0.115 | 0.056 | 0.115 | Aminopeptidase B inhibitor | |||
| 0.087 | 0.03 | 0.087 | Vanilloid 4 agonist | 0.084 0.034 CID_154699956 0.084 0.034 CID_154699550 | ||
| 0.055 | 0.006 | 0.055 | ATP citrate lysase inhibitor | 0.048 0.008 CID_154699956 0.048 0.008 CID_154699550 | ||
| 0.086 | 0.039 | 0.091 | Glutamate dehydrogenase inhibitor | 0.091 0.036 CID_154699956 0.091 0.036 CID_154699550 | CID_154699550 | |
| 0.054 | 0.009 | 0.054 | Liver X receptor beta agonist | 0.031 0.027 CID_154699956 | ||
| 0.062 | 0.018 | 0.062 | Aldosterone antagonist | 0.052 0.027 CID_154699956 0.052 0.027 CID_154699550 | ||
| 0.088 | 0.044 | 0.088 | Cell adhesion molecule inhibitor | |||
| 0.136 | 0.093 | 0.181 | Anticoagulant | 0.181 0.061 CID_154699956 0.122 0.109 CID_154699550 | CID_154699956 | |
| 0.069 | 0.028 | 0.069 | Carbonic anhydrase VB inhibitor | |||
| 0.051 | 0.013 | 0.051 | RNA-directed RNA polymerase inhibitor | |||
| 0.133 | 0.096 | 0.133 | Phospholipase A2 inhibitor | |||
| 0.079 | 0.043 | 0.079 | Aminopeptidase I inhibitor | 0.068 0.056 CID_154699956 0.068 0.056 CID_154699550 | ||
| 0.046 | 0.011 | 0.046 | Prostaglandin EP3 antagonist | 0.041 0.014 CID_154699956 0.041 0.014 CID_154699550 | ||
| 0.039 | 0.006 | 0.039 | Integrin alpha2beta1 antagonist | 0.028 0.015 CID_154699956 | ||
| 0.094 | 0.062 | 0.094 | Prolactin inhibitor | |||
| 0.074 | 0.042 | 0.074 | Carbonic anhydrase VA inhibitor | |||
| 0.064 | 0.032 | 0.064 | Beta 1 adrenoreceptor antagonist | |||
| 0.041 | 0.009 | 0.045 | Glutamate (mGluR3) agonist | 0.039 0.011 CID_154699956 0.045 0.006 CID_154699550 | CID_154699550 | |
| 0.046 | 0.015 | 0.067 | Glutamate (mGluR3) antagonist | 0.05 0.013 CID_154699956 0.067 0.007 CID_154699550 | CID_154699550 | |
| 0.037 | 0.007 | 0.037 | Alpha 2d adrenoreceptor agonist | 0.021 0.016 CID_154699550 | ||
| 0.035 | 0.005 | 0.035 | CC chemokine 8 receptor antagonist | 0.028 0.007 CID_154699956 0.028 0.007 CID_154699550 | ||
| 0.066 | 0.036 | 0.087 | Prostaglandin EP2 antagonist | 0.087 0.023 CID_154699956 0.087 0.023 CID_154699550 | CID_154699550 | |
| 0.055 | 0.03 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.053 0.032 CID_154699550 | ||
| 0.133 | 0.109 | 0.178 | Arachidonic acid antagonist | 0.178 0.056 CID_154699956 0.178 0.056 CID_154699550 | CID_154699550 | |
| 0.043 | 0.019 | 0.043 | Retinoid X receptor antagonist | |||
| 0.048 | 0.024 | 0.048 | AICAR transformylase inhibitor | 0.047 0.026 CID_154699956 0.047 0.026 CID_154699550 | ||
| 0.053 | 0.029 | 0.053 | HCV NS3/NS4A protease inhibitor | 0.047 0.038 CID_154699956 0.047 0.038 CID_154699550 | ||
| 0.113 | 0.092 | 0.113 | Bone formation stimulant | |||
| 0.037 | 0.016 | 0.037 | Carboxypeptidase B inhibitor | |||
| 0.104 | 0.082 | 0.104 | Cell adhesion inhibitor | 0.098 0.093 CID_154699550 | ||
| 0.145 | 0.123 | 0.145 | Succinate dehydrogenase inhibitor | |||
| 0.067 | 0.046 | 0.067 | Carbonic anhydrase V inhibitor | |||
| 0.059 | 0.038 | 0.059 | Potassium channel Kv1.5 blocker | |||
| 0.042 | 0.023 | 0.042 | Aggrecanase 1 inhibitor | |||
| 0.038 | 0.02 | 0.038 | AMPA receptor agonist | |||
| 0.035 | 0.016 | 0.035 | Trypsin II inhibitor | 0.028 0.023 CID_154699550 | ||
| 0.032 | 0.014 | 0.032 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.075 | 0.057 | 0.075 | CC chemokine receptor antagonist | |||
| 0.102 | 0.085 | 0.102 | Photosensitizer | |||
| 0.101 | 0.084 | 0.101 | Nav1.5 sodium channel blocker | |||
| 0.027 | 0.01 | 0.027 | Glutamate (mGluR1a) agonist | |||
| 0.053 | 0.038 | 0.053 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.051 | 0.037 | 0.051 | Carbonic anhydrase II stimulant | |||
| 0.04 | 0.026 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.085 | 0.071 | 0.085 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.032 | 0.019 | 0.041 | Prostaglandin D2 agonist | 0.041 0.012 CID_154699956 0.041 0.012 CID_154699550 | CID_154699550 | |
| 0.03 | 0.017 | 0.03 | Endothelin receptor antagonist | |||
| 0.06 | 0.048 | 0.06 | Trypsin inhibitor | |||
| 0.038 | 0.026 | 0.038 | G protein-coupled receptor agonist | |||
| 0.049 | 0.037 | 0.049 | Alpha 1b adrenoreceptor agonist | |||
| 0.038 | 0.026 | 0.044 | Glucose-6-phosphate dehydrogenase inhibitor | 0.044 0.017 CID_154699956 0.044 0.017 CID_154699550 | CID_154699550 | |
| 0.042 | 0.031 | 0.051 | Carbonic anhydrase IV inhibitor | 0.051 0.024 CID_154699956 0.051 0.024 CID_154699550 | CID_154699550 | |
| 0.091 | 0.08 | 0.091 | Carbonic anhydrase XV inhibitor | |||
| 0.036 | 0.025 | 0.036 | Glutamate (mGluR8) antagonist | |||
| 0.052 | 0.042 | 0.052 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.025 | 0.015 | 0.042 | Prostaglandin EP2 agonist | 0.042 0.008 CID_154699956 0.042 0.008 CID_154699550 | CID_154699550 | |
| 0.042 | 0.032 | 0.043 | Liver X receptor agonist | 0.043 0.031 CID_154699956 0.04 0.036 CID_154699550 | CID_154699956 | |
| 0.034 | 0.024 | 0.034 | Free fatty acid receptor 1 antagonist | |||
| 0.024 | 0.014 | 0.032 | Prostaglandin F2 alpha agonist | 0.032 0.008 CID_154699956 0.032 0.008 CID_154699550 | CID_154699550 | |
| 0.062 | 0.052 | 0.062 | Matrix metalloproteinase inhibitor | |||
| 0.04 | 0.031 | 0.04 | Kainate receptor agonist | 0.038 0.037 CID_154699956 0.038 0.037 CID_154699550 | ||
| 0.036 | 0.028 | 0.06 | Farnesoid X receptor agonist | 0.06 0.01 CID_154699956 0.046 0.018 CID_154699550 | CID_154699956 | |
| 0.023 | 0.015 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.006 CID_154699956 0.028 0.006 CID_154699550 | CID_154699550 | |
| 0.03 | 0.022 | 0.072 | Prostaglandin agonist | 0.072 0.007 CID_154699956 0.072 0.007 CID_154699550 | CID_154699550 | |
| 0.018 | 0.011 | 0.018 | G-protein-coupled receptor 120 agonist | |||
| 0.044 | 0.037 | 0.044 | GP IIb/IIIa receptor antagonist | |||
| 0.016 | 0.009 | 0.027 | Thromboxane A2 agonist | 0.027 0.004 CID_154699956 0.027 0.004 CID_154699550 | CID_154699550 | |
| 0.031 | 0.025 | 0.031 | Dipeptidyl peptidase II inhibitor | |||
| 0.013 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | 0.014 0.007 CID_154699550 | CID_154699550 | |
| 0.079 | 0.073 | 0.097 | Transcription factor NF kappa B stimulant | 0.097 0.042 CID_154699956 0.097 0.042 CID_154699550 | CID_154699550 | |
| 0.052 | 0.046 | 0.052 | Plasminogen activator inhibitor | |||
| 0.032 | 0.027 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.02 | 0.015 | 0.02 | Endothelin A receptor antagonist | |||
| 0.017 | 0.013 | 0.017 | Free fatty acid receptor 1 agonist | |||
| 0.043 | 0.04 | 0.049 | Beta adrenoreceptor agonist | 0.044 0.035 CID_154699956 0.049 0.02 CID_154699550 | CID_154699550 | |
| 0.032 | 0.028 | 0.032 | Glutamate (mGluR4) agonist | |||
| 0.041 | 0.038 | 0.041 | Glutamate (mGluR group III) antagonist | |||
| 0.048 | 0.045 | 0.081 | Carbonic anhydrase I inhibitor | 0.081 0.025 CID_154699956 | CID_154699956 | |
| 0.066 | 0.064 | 0.066 | Metalloproteinase-9 inhibitor | |||
| 0.024 | 0.023 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.029 0.018 CID_154699956 | CID_154699956 | |
| 0.056 | 0.055 | 0.056 | Bcl-xL inhibitor | |||
| 0.046 | 0.048 | 0.079 | Carbonic anhydrase II inhibitor | 0.079 0.025 CID_154699956 | CID_154699956 | |
| 0.085 | 0.088 | 0.115 | Anabolic | 0.115 0.045 CID_154699956 0.115 0.045 CID_154699550 | CID_154699550 | |
| 0.171 | 0.178 | 0.178 | Transcription factor STAT3 inhibitor | 0.178 0.167 CID_154699956 0.178 0.167 CID_154699550 | CID_154699550 | |
| 0.047 | 0.057 | 0.051 | Glucosylceramidase inhibitor | 0.051 0.045 CID_154699550 | CID_154699550 | |
| 0.006 | 0.019 | 0.014 | Thromboxane agonist | 0.014 0.005 CID_154699956 0.014 0.005 CID_154699550 | CID_154699550 | |
| 0.015 | 0.03 | 0.028 | Prostaglandin E2 agonist | 0.028 0.012 CID_154699956 0.028 0.012 CID_154699550 | CID_154699550 | |
| 0.045 | 0.062 | 0.085 | Carbonic anhydrase inhibitor | 0.085 0.033 CID_154699956 | CID_154699956 | |
| 0.055 | 0.079 | 0.065 | Beta 2 adrenoreceptor agonist | 0.059 0.053 CID_154699956 0.065 0.032 CID_154699550 | CID_154699550 | |
| 0.091 | 0.116 | 0.116 | Alpha-N-acetylglucosaminidase inhibitor | 0.116 0.081 CID_154699956 0.116 0.081 CID_154699550 | CID_154699550 | |
| 0.058 | 0.085 | 0.066 | CDC25A inhibitor | 0.066 0.063 CID_154699956 0.066 0.063 CID_154699550 | CID_154699550 | |
| 0.045 | 0.077 | 0.059 | Phosphofructokinase-1 inhibitor | 0.059 0.058 CID_154699956 0.059 0.058 CID_154699550 | CID_154699550 | |
| 0.023 | 0.056 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.028 CID_154699956 0.032 0.028 CID_154699550 | CID_154699550 | |
| 0.111 | 0.147 | 0.153 | Adenylate cyclase stimulant | 0.153 0.058 CID_154699956 0.153 0.058 CID_154699550 | CID_154699550 | |
| 0.075 | 0.116 | 0.098 | Adenylate cyclase inhibitor | 0.098 0.086 CID_154699956 0.098 0.086 CID_154699550 | CID_154699550 | |
| 0.047 | 0.092 | 0.073 | Lipocortins synthesis agonist | 0.073 0.019 CID_154699956 0.073 0.019 CID_154699550 | CID_154699550 | |
| 0.073 | 0.119 | 0.097 | Bile acid receptor antagonist | 0.097 0.055 CID_154699956 0.097 0.055 CID_154699550 | CID_154699550 | |
| 0.073 | 0.128 | 0.137 | AMP-activated protein kinase stimulant | 0.137 0.037 CID_154699956 0.137 0.037 CID_154699550 | CID_154699550 | |
| 0.071 | 0.135 | 0.109 | Cholesterol synthesis inhibitor | 0.109 0.076 CID_154699956 0.109 0.076 CID_154699550 | CID_154699550 | |
| 0.07 | 0.134 | 0.104 | DNA polymerase I inhibitor | 0.104 0.082 CID_154699956 0.104 0.082 CID_154699550 | CID_154699550 | |
| 0.099 | 0.168 | 0.204 | Growth hormone agonist | 0.204 0.057 CID_154699956 0.204 0.057 CID_154699550 | CID_154699550 | |
| 0.148 | 0.226 | 0.252 | Cholesterol antagonist | 0.252 0.124 CID_154699956 0.252 0.124 CID_154699550 | CID_154699550 | |
| 0.039 | 0.118 | 0.067 | Na+ K+ transporting ATPase inhibitor | 0.067 0.063 CID_154699956 0.067 0.063 CID_154699550 | CID_154699550 | |
| 0.114 | 0.196 | 0.194 | Immunostimulant | 0.194 0.124 CID_154699956 0.155 0.151 CID_154699550 | CID_154699956 | |
| 0.024 | 0.106 | 0.057 | Dopamine transporter inhibitor | 0.057 0.027 CID_154699550 | CID_154699550 | |
| 0.097 | 0.199 | 0.176 | Hepatoprotectant | 0.176 0.083 CID_154699956 0.176 0.083 CID_154699550 | CID_154699550 | |
| 0.079 | 0.187 | 0.206 | Angiogenesis stimulant | 0.206 0.091 CID_154699956 0.206 0.091 CID_154699550 | CID_154699550 | |
| 0.089 | 0.208 | 0.151 | Nitric oxide antagonist | 0.143 0.102 CID_154699956 0.151 0.094 CID_154699550 | CID_154699550 | |
| 0.203 | 0.33 | 0.552 | Antiinflammatory | 0.552 0.068 CID_154699956 0.34 0.18 CID_154699550 | CID_154699956 | |
| 0.082 | 0.21 | 0.143 | Farnesoid X receptor antagonist | 0.143 0.061 CID_154699956 0.143 0.061 CID_154699550 | CID_154699550 | |
| 0.061 | 0.191 | 0.102 | Microtubule formation inhibitor | 0.102 0.087 CID_154699956 0.102 0.087 CID_154699550 | CID_154699550 | |
| 0.131 | 0.275 | 0.245 | Vasodilator, peripheral | 0.245 0.131 CID_154699956 | CID_154699956 | |
| 0.12 | 0.267 | 0.225 | Transcription factor NF kappa B inhibitor | 0.193 0.176 CID_154699956 0.225 0.146 CID_154699550 | CID_154699550 | |
| 0.033 | 0.196 | 0.094 | Acetylcholine M3 receptor agonist | 0.094 0.049 CID_154699550 | CID_154699550 | |
| 0.068 | 0.41 | 0.201 | Immunosuppressant | 0.2 0.197 CID_154699956 0.201 0.196 CID_154699550 | CID_154699550 | |
| 0.018 | 0.645 | 0.209 | Vasodilator | 0.209 0.097 CID_154699956 | CID_154699956 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |